This article has been written and funded by the Boehringer Ingelheim & Lilly Alliance (Alliance) for UK and Irish healthcare professionals. Alliance products will be discussed at this meeting. The Alliance has provided funding towards the Diabetes Professional Care 2024 congress; however, it has had no input into the agenda, speaker selection, presentations or collateral content, except for this promotional symposium session.

The Alliance is committed to improving outcomes for people with type 2 diabetes and is delighted to be a gold sponsor of Diabetes Professional Care 2024. Come and join us at our sponsored symposium session on Wednesday 16ᵗʰ October. 

Around 3.96 million people in the UK currently live with type 2 diabetes and an additional estimated 1.2 million people are not yet diagnosed.(1) Cardiorenal complications are among the most significant health consequences associated with type 2 diabetes.(2,3) Cardiovascular disease (CVD) accounts for approximately one in four deaths for people with type 2 diabetes.(2) Chronic kidney disease (CKD) coexists in almost one third of people with type 2 diabetes and is projected to become the fifth leading cause of death by 2040.(3,4) In the UK alone, over 10% of the population are living with CKD, with around 44% of people not yet diagnosed.(5,6)

How can we work together as a community to improve outcomes for patients with type 2 diabetes and ensure guideline adoption in clinical practice? Among the potential solutions, peer-to-peer education within primary care will play a vital role, aiming to increase awareness of the burden of cardiorenal complications, the importance of screening for comorbidities such as CKD, and the latest treatment guidance.

References

• Diabetes UK. How many people in the UK have diabetes? Available at: https://www.diabetes.org.uk/about-us/about-the-charity/our-strategy/statistics (accessed September 2024).
• Pearson-Stuttard J et al. Lancet Diabetes Endocrinol. 2021;9(3):165–173.
• Cook S et al. BMJ Open. 2023;13(3):e065927.
• Kovesdy CP. Kidney Int Suppl (2011). 2022;12(1):7–11.
• Kidney Research UK. Kidney disease: a UK public health emergency. The health economics of kidney disease to 2033. 2023. Available at: https://www.kidneyresearchuk.org/wp-content/uploads/2023/06/Economics-of-Kidney-Disease-full-report_accessible.pdf. (accessed September 2024).
• Hirst JA et al. Br J Gen Pract. 2020;70(693):e285–e293.

NP-GB-104885  │  September 2024